Trial Profile
Prospective study of subcutaneous abatacept administration in rheumatoid arthritis patients as part of the Orencia Response Program (ORP) Network
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Feb 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 08 Feb 2016 New trial record